CD274 and neoplasm: Considering the immune checkpoint therapy, tumor cells often express PD-L1 responsible for induction of cytotoxic T cell exhaustion, and release PD-L1-expressing EVs that can abolish the effect of anti-PD-L1 or anti-PD-1 therapies [7,97].